CONTRATOS ART. 60
Contracte
A PHASE IV OPEN-LABEL CLINICAL TRIAL TO EVALUATE THE EFFICACY OF IKERVIS ON CLINICAL PARAMETERS AND MOLECULAR/CELLULAR BIOMARKERS IN DRY PATIENTS WITH SEVERE DERATITIS WHO HAVE NOT IMPROVED DESPITE REGULAR USE OF TEAR SUBSTITUTES BEFORE AND AFTER EXPOSURE TO AN ADVERSE CONTROLLED ENVIRONMENT.
Finançador :
SANTEN SA
date_range
Duració del 29 de d’abril de 2019 al 28 de d’abril de 2021
(24 mesos)
euro
60.677,20 EUR
D'àmbit Europeu.